Luvent 5mg chewable tablet contains montelukast. Montelukast is a lukoterine receptor antagonist used for the treatment of asthma and related symptoms. It produces its action by blocking the action of leukoterine D4 and cysteinyl leukoterine receptors in lungs or bronchial tubes by binding to it.
Wheezing and shortness of breath in asthma
Breathing problems in exercise
Decreases the use of inhaler
Hay fever and allergic rhinitis
Reduces the inflammation in airways
Once daily with or without food
It produces its action by selectively antagonizes leukoterine D4 (LTD4) at cysteinyl leukoterine receptor which is present in the body. By inhibiting the actions of CysLT1, it prevents the airway edema, smooth muscle contraction and enhanced secretion of viscous and thick fluid.
Absorption
After oral administration it gets rapidly absorbed with 64% of the bioavailability.
Distribution
Nearly about 64% of the drug is absorbed after oral administration with 99% of the drug bound to plasma protein. The drug follows hepatic metabolism.
Excretion
The drug is excreted through bile with elimination half life of 2.7-5.5 hrs. The clearance rate is 45mL/min in adults.
Abnormal dreams
Feeling restless
Depression
Inflammation of blood vessels in the skin
Hallucination
Involuntary quivering
Nervous
Increased eosinophils in the blood
If prescribed for the long term, then regular analysis should be mad
Allergic to any of the ingredient or previous allergy
Hepatic diseases
Chewable preparation contain aspartame should be cautiously used in patients with phenylketonuria (PKU) or any other condition that requires you to limit/avoid aspartame (or phenylalanine) in your diet
